Key Events This Week
15 Sep: Intraday low hit amid sharp 8.07% decline
16 Sep: Technical momentum shifts to mildly bullish despite price drop
18 Sep: Technical indicators upgrade to bullish with mixed returns
Week Close: Rs.249.35, down 5.30% vs Sensex -0.41%

Indoco Remedies Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Returns
2026-09-18 08:02:33Indoco Remedies Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend, signalling potential positive price action despite its mixed historical returns and a recent downgrade in its Mojo Grade to Sell. This analysis delves into the key technical indicators shaping the stock’s outlook and contextualises its performance against broader market benchmarks.
Read full news article
Indoco Remedies Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-09-16 08:05:09Indoco Remedies Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend as of mid-September 2026. Despite a sharp day decline of 8.07%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent technical parameter changes, placing them in the context of the company’s price action and broader market performance.
Read full news article
Indoco Remedies Ltd Hits Intraday Low Amid Price Pressure on 15 Sep 2026
2026-09-15 13:16:29Indoco Remedies Ltd experienced a notable decline today, touching an intraday low of Rs 244, reflecting a sharp price correction of 7.33% amid heightened volatility and broader market pressures. The stock underperformed its sector and the benchmark Sensex, signalling immediate selling pressure and cautious market sentiment.
Read full news articleIndoco Remedies Gains 0.48%: 4 Key Factors Driving the Week’s Volatility
2026-09-12 15:05:05
Key Events This Week
7 Sep: Stock declines 4.14% amid broader market weakness
8 Sep: Technical momentum shifts amid mixed market returns
9 Sep: Valuation metrics signal renewed price attractiveness
10 Sep: Intraday high with strong 8.72% surge
11 Sep: Technical momentum improves with 9.88% daily gain

Indoco Remedies Ltd is Rated Sell
2026-09-11 10:10:05Indoco Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 28 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Indoco Remedies Ltd Sees Technical Momentum Shift Amid Mixed Market Returns
2026-09-11 08:02:49Indoco Remedies Ltd has experienced a notable shift in price momentum, with technical indicators signalling a transition from mildly bullish to bullish trends. Despite a recent upgrade in its technical trend, the stock’s overall rating remains cautious, reflecting mixed signals from key momentum and volume indicators.
Read full news articleIndoco Remedies Limited - Press Release
01-Nov-2019 | Source : NSEIndoco Remedies Limited has informed the Exchange regarding a press release dated November 01, 2019, titled "Approval of Glycopyrrolate ANDAfiled from Indoco's Goa Plant II".
Indoco Remedies Limited - Updates
31-Oct-2019 | Source : NSEIndoco Remedies Limited has informed the Exchange regarding 'Publication of Unaudited Financial Results for the quarter and half year ended 30.09.2019 in newspapers'.
Indoco Remedies Limited - Press Release
18-Oct-2019 | Source : NSEIndoco Remedies Limited has informed the Exchange regarding a press release dated October 18, 2019, titled "Indoco s Clinical Research Organisation receives zero 483s from USFDA".
Corporate Actions
No Upcoming Board Meetings
Indoco Remedies Ltd has declared 10% dividend, ex-date: 10 Sep 26
Indoco Remedies Ltd has announced 2:10 stock split, ex-date: 17 May 12
Indoco Remedies Ltd has announced 1:2 bonus issue, ex-date: 17 May 12
No Rights history available








